Quantbot Technologies’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-58
Closed -$15.8K 2016
2025
Q1
$15.8K Buy
+58
New +$13.6K ﹤0.01% 1382
2023
Q2
Sell
-1,300
Closed -$280K 2040
2023
Q1
$280K Buy
+1,300
New +$312K 0.02% 792
2022
Q4
Sell
-1,146
Closed -$154K 2186
2022
Q3
$154K Sell
1,146
-2,654
-70% -$456K 0.01% 966
2022
Q2
$615K Buy
+3,800
New +$594K 0.06% 501
2021
Q4
Sell
-1,400
Closed -$508K 1991
2021
Q3
$508K Buy
+1,400
New +$458K 0.04% 603
2020
Q1
Sell
-800
Closed -$132K 1470
2019
Q4
$132K Buy
+800
New +$133K 0.01% 753
2019
Q3
Sell
-569
Closed -$70K 1616
2019
Q2
$70K Buy
+569
New +$72.2K 0.01% 832
2018
Q4
Sell
-1,748
Closed -$301K 1478
2018
Q3
$301K Sell
1,748
-4,599
-72% -$773K 0.02% 657
2018
Q2
$975K Buy
6,347
+4,619
+267% +$824K 0.07% 401
2018
Q1
$290K Buy
+1,728
New +$234K 0.03% 604
2017
Q4
Sell
-1,548
Closed -$160K 1527
2017
Q3
$160K Buy
+1,548
New +$115K 0.02% 746

Other funds holding ONC

Quantbot Technologies's ONC Position: Q2 2025 in Review

Quantbot Technologies sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 58 shares — an estimated $15.8K sold.

Quantbot Technologies first reported a position in ONC in Q3 2017 and held it in 11 quarters. The position peaked at $975K in Q2 2018. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Quantbot Technologies reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Quantbot Technologies sold 58 BeOne Medicines Ltd shares in Q2 2025, an estimated $15.8K.
  • Quantbot Technologies first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 11 quarters.
  • Quantbot Technologies's BeOne Medicines Ltd position peaked at $975K in Q2 2018.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Quantbot Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.